Psychiatry and Neurology, Neurology · Atlanta, GA
NPI
1548251572
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
4
Medicare group memberships
Hospitals
7
Hospital affiliations
3200 Downwood Cir NW, Ste 550
Atlanta, GA, 30327
Phone (404) 351-0205
Groups this clinician bills Medicare through
Medicare paid, 2024
$195K
6,502 services
Medicare patients, 2024
743
Average age 71
Drug cost, 2024
$7.1M
10,067 prescriptions
Company payments, 2025
$60K
From 38 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Douglas S Stuart was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 1,076 times for 532 patients. In total Douglas S Stuart billed 6,502 services in 44 codes, and Medicare paid $195K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-02-15.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,076 | 532 | $11.53 | $12K |
| 99214 Office E&M - Established | Office | 742 | 416 | $86.21 | $64K |
| 99213 Office E&M - Established | Office | 329 | 231 | $60.74 | $20K |
| 99215 Office E&M - Established | Office | 128 | 112 | $125.73 | $16K |
| 70551 MRI/MRA - Head and Neck | Office | 109 | 102 | $139.29 | $15K |
| 72141 MRI/MRA - Spine | Office | 60 | 59 | $95.68 | $5,741 |
| 95886 Electrical Nerve Conductivity | Office | 59 | 46 | $70.63 | $4,167 |
| 99222 Hospital E&M - Initial | Facility | 57 | 56 | $90.42 | $5,154 |
| 99205 Office E&M - New | Office | 55 | 55 | $142.16 | $7,819 |
| 99232 Hospital E&M - Subsequent | Facility | 51 | 36 | $56.34 | $2,874 |
| 95910 Electrical Nerve Conductivity | Office | 22 | 22 | $131.59 | $2,895 |
| 99231 Hospital E&M - Subsequent | Facility | 15 | 12 | $35.54 | $533 |
| 96138 Behavioral Health Services | Office | 13 | 13 | $21.35 | $278 |
| 99204 Office E&M - New | Office | 13 | 13 | $116.67 | $1,517 |
| 99204 Office E&M - New | Facility | 12 | 12 | $90.80 | $1,090 |
By year: 2022 $159K for 5,999 services; 2023 $157K for 4,486 services; 2024 $195K for 6,502 services.
Medicare prescription drug claims, 2024
In 2024, the drug Douglas S Stuart prescribed most often to Medicare patients was Gabapentin, with 606 prescriptions and refills. In total Douglas S Stuart wrote 10,067 Medicare prescriptions that cost $7.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 606 | 993 | 161 | $17K |
| Clonazepam Generic | 478 | 545 | 88 | $2,701 |
| Baclofen Generic | 385 | 704 | 112 | $11K |
| Donepezil Hcl Generic | 384 | 735 | 113 | $3,972 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 376 | 400 | 68 | $10K |
| Dimethyl Fumarate Generic | 274 | 302 | 35 | $140K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 264 | 265 | 46 | $6,509 |
| Zolpidem Tartrate Generic | 243 | 297 | 45 | $1,641 |
| Alprazolam Generic | 213 | 243 | 62 | $1,330 |
| Tizanidine Hcl Generic | 197 | 354 | 61 | $2,439 |
| Duloxetine Hcl Generic | 194 | 354 | 44 | $3,068 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 186 | 329 | 42 | $6,458 |
| Escitalopram Oxalate Generic | 177 | 258 | 30 | $1,327 |
| Prednisone Generic | 169 | 199 | 90 | $882 |
| Pregabalin Generic | 160 | 206 | 32 | $4,778 |
Brand drugs: - claims; generic drugs: 9,105 claims; opioid claims: 643.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Douglas S Stuart $60K ($60K in general payments such as food, travel and fees) from 38 companies. The largest payer was TG Therapeutics, Inc. with $33K.
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. TGTX | 43 | $33K |
| Amgen Inc. AMGN | 24 | $16K |
| E.R. Squibb & Sons, L.L.C. BMY | 8 | $7,449 |
| EMD Serono, Inc. MRK.DE | 41 | $617 |
| Abbvie Inc. ABBV | 17 | $382 |
| Novartis Pharmaceuticals Corporation NVS | 18 | $307 |
| Biogen, Inc. BIIB | 5 | $262 |
| Argenx US, Inc. ARGX | 6 | $258 |
| UCB, Inc. UCB.BR | 7 | $249 |
| Celgene Corporation BMY | 3 | $151 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.